Originally published In Press as doi:10.1074/jbc.M111750200 on February 8, 2002
J. Biol. Chem., Vol. 277, Issue 16, 14227-14237, April 19, 2002
Differential Use of Myristoyl Groups on
Neuronal Calcium Sensor Proteins as a Determinant of Spatio-temporal
Aspects of Ca2+ Signal Transduction*
Dermott W.
O'Callaghan
,
Lenka
Ivings
,
Jamie L.
Weiss,
Michael C.
Ashby
,
Alexei V.
Tepikin, and
Robert D.
Burgoyne§
From the Physiological Laboratory, University of Liverpool, Crown
Street, Liverpool L69 3BX, United Kingdom
Received for publication, December 10, 2001, and in revised form, February 6, 2002
 |
ABSTRACT |
The localizations of three members of the
neuronal calcium sensor (NCS) family were studied in HeLa cells. Using
hippocalcin-EYFP and NCS-1-ECFP, it was found that their localization
differed dramatically in resting cells. NCS-1 had a distinct
predominantly perinuclear localization (similar to trans-Golgi
markers), whereas hippocalcin was present diffusely throughout the
cell. Upon the elevation of intracellular Ca2+,
hippocalcin rapidly translocated to the same perinuclear compartment as
NCS-1. Another member of the family, neurocalcin
, also translocated to this region after a rise in Ca2+ concentration.
Permeabilization of transfected cells using digitonin caused loss of
hippocalcin and neurocalcin
in the absence of calcium, but in the
presence of 10 µM Ca2+, both proteins
translocated to and were retained in the perinuclear region. NCS-1
localization was unchanged in permeabilized cells regardless of calcium
concentration. The localization of NCS-1 was unaffected by mutations in
all functional EF hands, indicating that its localization was
independent of Ca2+. A minimal myristoylation motif
(hippocalcin-(1-14)) fused to EGFP resulted in similar perinuclear
targeting, showing that localization of these proteins is because of
the exposure of the myristoyl group. This was confirmed by mutation of
the myristoyl motif of NCS-1 and hippocalcin that resulted in both
proteins remaining cytosolic, even at elevated Ca2+
concentration. Dual imaging of hippocalcin-EYFP and cytosolic Ca2+ concentration in Fura Red-loaded cells demonstrated
the kinetics of the Ca2+/myristoyl switch in living
cells and showed that hippocalcin rapidly translocated with a half-time
of ~12 s after a short lag period when Ca2+ was elevated.
These results demonstrate that closely related Ca2+
sensor proteins use their myristoyl groups in distinct ways in vivo in a manner that will determine the time course of
Ca2+ signal transduction.
 |
INTRODUCTION |
Calcium is a widely used intracellular signal that regulates many
different cellular processes in a very specific manner. An aspect that
has received considerable attention in recent years is the varied use
of Ca2+ signal mechanisms that determine spatio-temporal
aspects of the changes in Ca2+ concentration (1). The
existence of highly localized changes in Ca2+ concentration
in addition to global Ca2+ changes has been increasingly
highlighted, and these local Ca2+ signals are likely to
contribute to the specificity of Ca2+ actions (2). The
specificity of Ca2+ signaling is also the result, in part,
of the existence of many different Ca2+-binding proteins,
which act as Ca2+ sensors in the transduction of
Ca2+ signals. Localization of Ca2+ sensors
could be a significant factor, and the effect of localization of
Ca2+ sensors on signal transduction has been examined for
two such proteins. Calmodulin responds to global Ca2+
changes by binding Ca2+ and then subsequently to target
proteins; it can also translocate into the nucleus (3-5). Protein
kinase C isoforms also show specific patterns of translocation to the
plasma membrane (6). Analysis of the factors that determine the
localization of other Ca2+ sensors is likely to be crucial
for further understanding of Ca2+ signal transduction, but
has so far been little studied.
The neuronal calcium sensor
(NCS)1 proteins are a family
of high affinity Ca2+-binding proteins that can sense
Ca2+ elevations above resting Ca2+
concentration in the range of 0.1-1.0 µM (7). The NCS
family includes proteins expressed only in retinal photoreceptors
(recoverin (Ref. 8) and the GCAPs (Ref. 9)) or in neurons, in some cases most highly in particular cell types (hippocalcin (Ref. 10),
neurocalcins/VILIPs (Ref. 11)) or with more widespread expression
(NCS-1/frequenin (Refs. 12 and 13)). All the NCS family members share
four characteristic EF hands and a myristoylated N terminus. In the NCS
proteins, three (or only two in some family members) of the four EF
hands are capable of binding calcium and the EF hand nearest the N
terminus (EF1) is altered so that it cannot bind Ca2+ (7).
The myristoyl tail is a fatty acid post-translationally added to the
NCS protein. Its function has been extensively studied in recoverin
(14). In recoverin, the myristoyl group is buried in a nonpolar pocket
formed by EF1 and the surrounding region in the Ca2+-free
state (15). When recoverin binds calcium, there is a large conformational change that ejects the myristoyl group from its pocket
(16). This exposed hydrophobic tail is then free to interact with the
nonpolar cell membranes or hydrophobic protein domains. This exposure
of the myristoyl tail on calcium binding is referred to as a
"calcium/myristoyl switch" and considered to be primarily a
mechanism by which the protein can translocate from the cytosol to
intracellular membranes (14, 16). The structural features required for
the Ca2+/myristoyl switch are apparently conserved in all
NCS proteins. The presence of this Ca2+-mediated
membrane-association process was, therefore, suggested for the other
members of the neuronal calcium sensor protein family (16). There are
biochemical data from disrupted cells for some of the family members in
support of this mechanism (17, 18). A clear understanding of the
localization and translocation of these proteins in response to calcium
will allow the generation of models of how these proteins modulate and
integrate calcium signals. There has, however, been little in
vivo work to demonstrate the Ca2+/myristoyl switch
during elevation of Ca2+ concentration within live cells,
and so kinetic aspects of the proposed membrane translocation are unknown.
In this study we have examined the potential Ca2+-myristoyl
switch in three NCS proteins. Hippocalcin is expressed most highly in
hippocampal neurons (19) and the closely related neurocalcin
(VILIP-3) in cerebellar Purkinje cells (20, 21). Biochemical studies
with these proteins suggest Ca2+-dependent
membrane interactions (17, 18), but this has not been examined within
intact cells. The functions of these two proteins are unknown. In
contrast, NCS-1 has been shown to play crucial roles in learning and
memory in Caenorhabditis elegans (22), in the release of
neurotransmitters (12) and hormones (23, 24), and in the regulation of
voltage-gated Ca2+ channels (25, 26). In addition, the
yeast orthologue of NCS-1 is essential for survival as a regulator of
the PI 4-kinase, Pik1 (27). Unlike the other NCS proteins, NCS-1 is
found outside of the nervous system (23, 28) and may be a regulator of
mammalian Golgi-associated PI 4-kinase
in non-neuronal cells (29).
Biochemical data suggest that, in contrast to other NCS proteins, NCS-1
can bind to isolated membranes in the absence of Ca2+ (24).
We have prepared enhanced GFP-variant constructs of these proteins to
compare their Ca2+/myristoyl switch mechanisms. We
demonstrate different uses of N-terminal myristoylation, which would
generate distinct spatio-temporal Ca2+ sensing by members
of the NCS family and have assessed the kinetics of the
Ca2+/myristoyl switch-dependent membrane
translocation in living cells.
 |
MATERIALS AND METHODS |
Plasmids--
The EYFP-tagged hippocalcin fusion construct
(pHippo-EYFP) was made by the in-frame insertion of a hippocalcin
sequence, amplified from rat brain cDNA, into the pEYFP-N1 vector
(CLONTECH). The primers contained endonuclease
sites (underlined) to facilitate this cloning. The primers were based
on the rat nucleotide sequence (GenBankTM accession no. NM017122). The
sense primer was designed to the 5'-untranslated region from
165 to
135 (5'-GGCCGGCTAGCTCTTTTTGGGTCAAATGAG-3'; NheI) and the antisense primer with a mutated stop codon to
the region +735 to +765
(5'-CCTCTCACTCGAGAACTGGGAAGCGCTGCT-3'; XhoI). The amplified sequence digested with the endonucleases
NheI/XhoI was cloned into the vector pEYFP-N1
digested with the endonucleases NheI/SalI using
standard methods. The ECFP-tagged NCS-1 fusion construct (pNCS-1-ECFP)
was made by the in-frame insertion of a NCS-1 sequence, amplified from
the pNCS-1 plasmid (23), into the pECFP-N1 vector
(CLONTECH). The primers contained endonuclease sites (underlined). The sense primer was designed to the region from 0 to +30 (5'-ATACGGTACCATGGGGAAATCCAACAGCAAG-3';
KpnI) and the antisense primer to the region from +492 to
+522 (5'-ATGCGGTACCAATACCAGCCCGTCGTAGAGGG-3'; KpnI). The amplified sequence digested with KpnI
was inserted into the vector pEYFP-N1 digested with KpnI
using standard methods.
The pHippo-(1-14)-EGFP construct was made by the endonuclease
digestion of pHippo-EYFP using PstI/NotI. This
removed all the hippocalcin and EYFP sequences except for the first 14 codons of the hippocalcin sequence, including the 10 codons required for myristoylation. Into this construct was ligated the coding sequence
for EGFP. The nonmyristoylatable hippocalcin and NCS-1 fusion
constructs (pHippo(G2A)-EYFP and pNCS-(1(G2A)-ECFP) were both made
using the QuikChangeTM site-directed mutagenesis kit (Stratagene
Europe, Amsterdam, The Netherlands). The primers used for hippocalcin
were 5'-TTGGCTCTTCTGCCATGGCCAAGCAGAATAGCAAGCTGCG-3' (sense) and
5'-CGCAGCTTGTATTCTGCTTGGCCATGGCAGAAGAGCCAA-3' (antisense). The primers
used for pNCS were 5'-CTGCAGTCGACGGTACCATGGCGAAATCCAACAGCAAGTT-3' (sense) and 5'-AACTTGCTGTTGGATTTCGCCATGGTACCGTCGACTGCAG-3' (antisense).
The neurocalcin
plasmid (pNeurocalcin
) was made by the
insertion of the bovine neurocalcin
sequence, amplified from the
pDL1312 vector (18) (kindly provided by Daniel Ladant, Institut Pasteur, Paris, France), into the pcDNA 3.1(
) vector (Invitrogen, Groningen, The Netherlands). The primers contained endonuclease sites
(underlined) to facilitate this cloning. The sense primer used was
5'-CCAGGATCCATGGGCAAGCAGAACAGCAA-3' (BamHI), and
the antisense primer was 5'-CCGAAGCTTTCAGAACTGGCTAGCACT-3'
(HindIII). The NCS-1 EF hand mutant construct,
pNCS-1EF2-4, was made using pNCS-1 as a template and the
QuikChangeTM site-directed mutagenesis kit (Stratagene Europe). Three
pairs of primers were used sequentially, one pair for each EF hand. The
primers used for EF2 were
5'-GCAGGATCGAGTTCTCCCAATTCATCCAGGCTC-3' (sense) and 5'-GAGCCTGGATGAATTGGGAGAACTCGATCCTGC-3' (antisense). The primer pair
used for EF3 were 5'-CACCAGAAACCAGATGCTGGACATAGTCGACGCCATTTACC-3' (sense) and 5'-GGTAAATGGCGTCGACTATGTCCAGCATCTGGTTTCTGGTG-3'
(antisense). The primer pair used for EF4 were
5'-AACTCTTCAGCAGTTCCAGGAAGGATCCAAGGCCG-3' (sense) and
5'-CGGCCTTGGATCCTTCCTGGAACTGCTGAAGAGTAG-3' (antisense).
The sequence of all these constructs were confirmed by automated
sequencing by Oswel (Southampton, United Kingdom (UK)).
Culture and Transfection of HeLa Cells--
HeLa cells were
maintained in Dulbecco's modified Eagle's medium (Invitrogen,
Paisley, UK) containing 5% fetal calf serum (Invitrogen) and 1%
nonessential amino acids (Invitrogen), incubated at 37 °C in an
atmosphere of 5% CO2 and plated onto glass coverslips in a
24-well plate at 40,000 cells/well. The cells were allowed 4-24 h to
adhere before they were transfected. The transfection reaction mixture
contained 93 µl of Dulbecco's modified Eagle's medium (Invitrogen),
3 µl of FuGENETM (Roche), and 4 µl of plasmid DNA (250 µg/µl).
This was incubated at room temperature for 30 min before being added
dropwise to HeLa cells in a 24-well plate. The cells were maintained
for 8-96 h before being used in experiments.
Immunofluoresence Staining--
Anti-NCS-1 was prepared in
rabbits as described previously (23). Anti-neurocalcin
was prepared
as a rabbit antiserum using a similar protocol in which rabbits were
immunized with purified recombinant neurocalcin
expressed in
Escherichia coli and affinity-purified on immobilized
recombinant neurocalcin
. Anti-
-adaptin was from Sigma (Poole,
UK), anti-GFP from CLONTECH (Basingstoke, UK),
and anti-transferrin receptor from Roche (East Sussex, UK). Cells attached to coverslips were washed twice in phosphate-buffered saline
(PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM
NaH2PO4), and fixed in PBS containing 4%
formaldehyde for 30 min. The cells were washed twice in PBS and
incubated in blocking buffer (0.3% bovine serum albumin, 0.5% Triton
X-100 in PBS) for 1 h. The blocking buffer was removed and the
primary antibody added at the appropriate dilution (anti-
-adaptin 1 in 100, anti-GFP 1 in 400, anti-transferrin receptor 1 in 400, anti
NCS-1 1 in 1,000, and anti neurocalcin
1 in 100). The primary
antibody was incubated for 1-2 h and removed, and the cells were
washed three times in blocking buffer. The cells were then incubated
for an additional 1 h with the appropriate biotinylated secondary
antibody diluted to 1 in 100, (anti-rabbit for anti-NCS-1 and
anti-neurocalcin
primary antibodies and anti-mouse for the other
primary antibodies; Amersham Biosciences, Buckinghamshire, UK).
The cells were washed three times and then incubated in
streptavidin-Texas Red (Amersham Biosciences) diluted 1 in 50 for 30 min. The cells were washed three times, and the coverslips were dried
and mounted on antifade glycerol (glycerol/PBS 9:1, 0.25%
diazabicyclo(2-2-2)octane, 0.002% p-phenyldiamine).
The cells were examined on a Zeiss Universal microscope and
fluorescence imaged using the following standard Zeiss filter sets:
ECFP BG3+LP400, FT460, LP495; EYFP, BP450-490, FT510, BP515-565;
Texas Red, BP546/12, FT850, LP590.
Polyacrylamide Gel Electrophoresis and Western Blotting--
The
cells of each well in a 24-well plate were lysed using 100 µl of
Laemmli buffer (Sigma, Dorset, UK)/well and boiled for 10 min. The
samples were loaded onto and separated using a 15% SDS-polyacrylamide
gel and then blotted onto nitrocellulose by transverse electrophoresis.
The nitrocellulose membranes were washed twice in PBS and placed in
blocking buffer (PBS containing 5% bovine serum albumin, 5% fetal
calf serum, 5% MarvelTM milk powder, 0.5% Tween 20TM) for 1 h.
The PBT was removed and the primary antibody added at the appropriate
dilution in PBS, 3% MarvelTM milk powder (anti-NCS-1 at 1in 1000, affinity-purified anti-neurocalcin
at 1 in 400, and anti-GFP at 1 in 400 from CLONTECH, Basingstoke, UK). The primary
antibody was incubated for 1-2 h and removed, and the membranes were
washed three times. The membranes were then incubated for an additional
1 h with the appropriate horseradish peroxidase-conjugated
secondary antibody diluted to 1 in 400 with PBT, (anti-rabbit for
anti-NCS-1 and anti-neurocalcin
primary antibodies and anti-mouse
for anti-GFP primary antibodies; Sigma). The membranes were washed once
in PBT, three times in PBS, and once with distilled water. The signal
was detected using enhanced chemiluminescence (Amersham Biosciences).
Stimulation of Cells with Ionomycin and Imaging of Fixed
Cells--
Transfected HeLa cells were washed three times in
Krebs-Ringer buffer (145 mM NaCl, 5 mM KCl, 1.3 mM MgCl2, 1.2 mM
NaH2PO4, 10 mM glucose, 20 mM HEPES, pH 7.4). The cells were then incubated for 10 min
in 1 µM ionomycin in Krebs-Ringer buffer in the presence or absence of 3 mM CaCl2 at 37 °C. The
Krebs-Ringer buffer was removed, and the cells were fixed in 4%
formaldehyde for immunofluorescence staining and imaged using a Zeiss
Universal microscope fitted with a Nikon Coolpix 995 digital camera.
Confocal Laser Scanning Microscopy on Living Cells--
For
confocal laser scanning microscopy, live transfected HeLa cells were
examined with a Leica TCS-SP-MP microscope (Leica Microsystems,
Heidelberg, Germany) using a 166.27-µm pin-hole and a 63× water
immersion objective with a 1.2 numerical aperture. For optimal imaging
of the spatial distribution of hippocalcin-EYFP, the cells were excited
at 514 nm and light collected at 545-625 nm and fluorescence images
were collected every 1.86 s with alternate phase-contrast images
to check for changes in cell morphology. For dual imaging of
hippocalcin-EYFP and NCS-1-ECFP, the cells were excited at 514 nm with
light collected at 560-600 nm for EYFP or excited at 458 nm for and
light collected at 465-500 nm for ECFP detection. In experiments on
the kinetics of Ca2+-dependent translocation,
cells were loaded with Fura Red (Molecular Probes) by incubation in 5 µM Fura Red in growth medium for 30 min. The cells were
then excited at 488 nm and light collected at 625-725 nm for Fura Red
emission and at 525-590 for hippocalcin-EYFP emission and images
collected every 137 ms. Ionomycin was added to the bath solution a
final concentration of 3 µM.
Permeabilization Experiments--
Transfected HeLa cells were
washed three times in Krebs-Ringer buffer and incubated for 15 min in
10 µM digitonin in 300 µl of permeabilization buffer
(139 mM potassium glutamate, 20 mM PIPES, 5 mM EGTA, pH 6.5) in the presence or absence of 10 µM free calcium at 37 °C. If the cells were to be
fixed, the buffer was removed and 500 µl of 4% formaldehyde was
added per well. For the leakage experiments, the permeabilization
buffer was removed and centrifuged briefly at 12,000 rpm to sediment
any detached cells. The proteins were concentrated by precipitation
with cold methanol (30) and resuspended in 100 µl of Laemmli buffer
(Sigma). The cells remaining in the wells were solubilized in Laemmli
buffer. All samples were boiled for 10 min and then used for
polyacrylamide gel electrophoresis and Western blotting.
 |
RESULTS |
Expression and Localization of NCS Proteins in HeLa Cells--
To
determine the localization of the neuronal calcium sensing proteins
NCS-1 and hippocalcin in living cells, constructs were made that fused
the C terminus of these proteins to the fluorescent proteins ECFP and
EYFP to produce the plasmids pNCS-1-ECFP and pHippo-EYFP, respectively.
Vector-derived sequence produced a 10- or 13-amino acid linker
between the NCS-1 protein and hippocalcin, respectively, and the
fluorescent protein. These constructs were transfected into HeLa cells,
which do not express detectable levels of the proteins endogenously,
and the expressed proteins observed in living and fixed cells. HeLa
cells were chosen as a convenient cell type to allow examination of the
basic localization and translocation mechanism of these proteins within
a cellular environment. To demonstrate their correct expression,
Western blots were carried out on samples from transfected cells. Fig.
1 shows that the expressed fusion
proteins were of the expected size (~60 kDa) and recognized by both
anti-GFP and specific antibodies. Anti-NCS-1 was used for cells
transfected with pNCS-1-ECFP. Expression of Hippo-EYFP could be
demonstrated using an antiserum prepared against the closely related
protein neurocalcin
(96% identical (Ref. 7)). The 60-kDa band
representing the fusion proteins was not seen in samples from cells
transfected with the control vectors pEYFP-N1 and pECFP-N1 but instead
a polypeptide band corresponding to the free fluorescent proteins.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 1.
Demonstration of fusion protein expression in
transfected HeLa cells. Western blots used an anti-GFP antibody
(A and C), an anti-NCS-1 antibody (B),
or an anti-neurocalcin antibody with cross-reactivity for
hippocalcin (D). The samples were lysates from cells
transfected with pNCS-1-ECFP, pHippo-EYFP, pECFP-N1, and pEYFP-N1. A
polypeptide was detected with both the anti-GFP and anti-NCS-1
antibodies at the expected size (60 kDa) in cells transfected with
pNCS-1-ECFP. A polypeptide was also detected with both the anti-GFP and
anti-neurocalcin antibodies at the expected size (60 kDa) in cells
transfected with pHippo-CFP. This demonstrated that both fusion
proteins were being expressed correctly. For both the controls,
pEYFP-N1 and pECFP-N1, the only band detected with any of the
antibodies was a 27-kDa band, corresponding to EYFP or ECFP, using the
anti-GFP antibody.
|
|
Fig. 2 shows the localization of proteins
encoded by pNCS-1-ECFP, pHippo-EYFP, and constructs expressing the free
fluorescent proteins ECFP and EYFP. The location patterns were not
dependent upon expression levels of the proteins and were
indistinguishable in cells transfected for between 8 and 96 h and
with varying levels of fluorescence intensity at each time point. The
free fluorescent proteins were found in the cytoplasm but were
particularly concentrated in the nucleus (Fig. 2, A and
B). The hippocalcin-EYFP fusion protein was present in the
cytoplasm and also in the nucleus but to a lesser extent than ECFP or
EYFP (Fig. 2C). The NCS-1 fusion protein, in contrast, had a
radically different distribution. The fluorescence of NCS-1-ECFP was at
its most intense in a perinuclear region to one side of the nucleus,
whereas the nucleus was devoid of fluorescence (Fig. 2D).
Additionally, NCS-1 ECFP was also associated with plasma membrane,
usually in a patchy distribution. The presence of the ECFP and EYFP
tags did not influence the localization of the NCS proteins, as similar
localization patterns were seen with wild-type protein detected by
immunofluorescence (shown below). In addition, similar localization
patterns were seen in living and fixed cells. Previous work has shown
that endogenous NCS-1 in COS cells is also localized to a perinuclear
compartment that overlaps partially with the trans-Golgi network marker
-adaptin (28). Fig. 3
(A-C) shows that ECFP-NCS-1 also partially co-localizes with
-adaptin. In contrast, ECFP-NCS-1 did not significantly co-localize with the transferrin receptor used as a marker of endosomal
compartments (Fig. 3, D-F).

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 2.
Differences in localization of fluorescent
proteins in HeLa cells. The cells were transfected with pEYFP-N1
(A), pECFP-N1 (B), pHippo-EYFP (C), or
pNCS-1-ECFP (D). Expressed ECFP-N1 and YFP-N1 was found
diffusely throughout the cell but with an accumulation of fluorescence
in the nucleus. Expressed hippocalcin-EYFP had a similar pattern of
fluorescence but at lower levels in the nucleus. The expression of
NCS-1-ECFP differed radically from the other proteins with fluorescence
being concentrated in a perinuclear region of the cell. The plasmids
used are shown schematically below each panel.
The scale bar represents 20 µm.
|
|

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 3.
Comparison of the intracellular localization
of NCS-1-ECFP (B and E) with the
trans-Golgi marker -adaptin
(A) and the endosomal marker transferrin receptor
(D). Partial co-localization can be seen between
the -adaptin and NCS-1-ECFP, shown by the yellow in the
overlay (C). The cell on the left in A
is a nontransfected cell in which the -adaptin localization was
similar to those cells expressing NCS-1-ECFP. There was little
co-localization between NCS-1-ECFP expression and the transferrin
receptor (F), showing that NCS-1 was not present at
significant levels on early endosomes. The scale
bar represents 20 µm.
|
|
Effect of Ca2+ Elevation on Localization of NCS
Proteins--
The effect of a global elevation in intracellular
Ca2+ concentration on the localization of the NCS fusion
proteins was assessed by treating cells with 1 µM
ionomycin in the presence of external Ca2+. The NCS-1
fusion protein did not change its localization in response to an
increase in intracellular Ca2+ levels (Fig.
4, A and B). This
suggests that, at both resting and raised levels of Ca2+,
NCS-1 has its myristoyl tail exposed allowing membrane association. In
contrast, following Ca2+ elevation, the hippocalcin fusion
protein translocated from its apparent diffuse cytosolic localization
to a predominantly perinuclear pattern (Fig. 4, C and
D). This perinuclear localization appeared to be very
similar to that seen with the NCS-1 fusion protein at resting
Ca2+ levels. A more diffuse localization was also present,
spreading out to the cell periphery consistent with an additional
patchy plasma membrane localization. The
Ca2+-dependent translocation of
hippocalcin-EYFP was rapidly reversed when the external buffer was
exchanged for a buffer without added Ca2+ (data not shown).
In cells transfected with a construct expressing an untagged version of
neurocalcin
, another member of the NCS family that is closely
related to hippocalcin (7), a similar diffuse localization was seen in
unstimulated cells using immunofluorescence to detect the protein in
fixed cells (Fig. 4E). Translocation of neurocalcin
to
the perinuclear region plasma membrane structures was also observed
following an increase in intracellular Ca2+ by ionomycin
treatment (Fig. 4F). The apparent translocation of
hippocalcin and neurocalcin
from the cytosol to membranes is
consistent with the proposed Ca2+/myristoyl switch
mechanism and suggests that these proteins only become
membrane-associated at cytosolic Ca2+ concentrations
above those in resting cells.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 4.
The effect of raising the intracellular
calcium concentration using the calcium ionophore ionomycin on the
localization of NCS proteins. A and B, cells
expressing hippo-EYFP; C and D, cells expressing
NCS-1-ECFP; E and F, cells expressing neurocalcin
and stained with anti-neurocalcin antiserum. Cells were
incubated in the absence (control) or presence of 1 µM
ionomycin. Both hippocalcin-EYFP and neurocalcin translocated to
the perinuclear compartment in cells treated with ionomycin. NCS-1-ECFP
localization was unaffected by ionomycin treatment. The plasmids used
are shown schematically below each panel. The
scale bar represents 20 µm.
|
|
In fixed cells the localization of hippocalcin-EYFP after ionomycin
treatment was similar to the perinuclear localization of NCS-1-ECFP.
The extent of co-localization of the two proteins in living cells was
examined directly using laser scanning confocal microscopy of cells
transfected to express both hippocalcin-EYFP and NCS-1-ECFP. In resting
cells, hippocalcin-EYFP showed a diffuse localization (Fig.
5A). In contrast, NCS-1-ECFP
was associated with the perinuclear compartment and also had a patchy
distribution on the plasma membrane (Fig. 5B). Following
treatment with ionomycin for 2 min, hippocalcin-EFYP was observed to
have translocated (Fig. 5D). A proportion of
hippocalcin-EYFP remained in the nucleus but in the rest of the
cell showed almost complete co-localization with NCS-1-CFP (Fig. 5,
D-F).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Hippocalcin-EYFP and NCS-1-ECFP show similar
localizations in co-transfected HeLa cells stimulated with
ionomycin. HeLa cell were co-transfected to express both
hippocalcin-EYFP and NCS-1-ECFP and living cells examined using
confocal laser scanning microscopy. Before ionomycin treatment
hippocalcin-EYFP (A) was diffusely distributed, whereas
NCS-1-ECFP (B) was concentrated in the perinuclear
compartment and on plasma membrane patches with little overlap with
hippocalcin-EYFP (C). After treatment with ionomycin for 2 min, hippocalcin-ECFP (D) and NCS-1-ECFP (E) were
both localized to the same regions except that hippocalcin-EYFP was
also seen in the nucleus. Extensive co-localization was evident in the
overlapped image (F). The scale bar
represents 20 µm.
|
|
The data from intact cells on the effects of raising Ca2+
with ionomycin are consistent with membrane association of NCS-1-ECFP even at low Ca2+ concentration and
Ca2+-dependent translocation of cytosolic
hippocalcin-EYFP and neurocalcin
to membranes. To confirm this
interpretation, the localization of the proteins was examined after
digitonin permeabilization to allow soluble proteins to leak out of the
cells. Transfected cells were permeabilized with 10 µM
digitonin in a buffer containing either 0 or 10 µM free
Ca2+. At 10 µM free Ca2+
concentration, the hippocalcin fusion protein translocated to the
perinuclear compartment as seen with ionomycin treatment (Fig. 6). Cells transfected with the
pNCS-1-ECFP also retained their perinuclear fluorescence after
permeabilization in 10 µM Ca2+. These results
showed that the perinuclear localization was because of the fusion
proteins associating with intracellular structures. When transfected
cells were permeabilized in a buffer containing 0 Ca2+,
essentially all fluorescence was rapidly lost from
pHippo-EYFP-transfected cells except a small amount that remained
trapped in the nucleus. The hippocalcin fusion protein was, therefore,
essentially completely cytosolic at 0 Ca2+ levels and free
to diffuse from the permeabilized cells. Permeabilization of
pNCS-1-CFP-transfected cells in 0 Ca2+ buffer did not
affect the fluorescence pattern. The NCS-1 fusion protein remained
attached to the perinuclear membrane construct regardless of the
presence or absence of Ca2+ (Fig. 6). The data from
examination of fluorescence were confirmed by biochemical analysis
using Western blotting of cells and medium containing leaked proteins
(Fig. 7). The majority of the NCS-1-ECFP was retained in the permeabilized cells irrespective of
Ca2+ concentration (Fig. 7). In contrast, the majority of
hippocalcin-YFP leaked into the medium at 0 Ca2+ but the
protein was fully retained in cells at 10 µM free
Ca2+ (Fig. 7). Retention was half-maximal at ~0.2-0.3
µM free Ca2+ (data not shown). Similar
Ca2+-dependent translocation to the perinuclear
region (Fig. 6, E and F) and
Ca2+-dependent retention in permeabilized cells
(Fig. 7) was seen in cells transfected with untagged neurocalcin
with expression detected using anti-neurocalcin
antiserum. The
extent of retention of the NCS proteins in the presence of
Ca2+ (Fig. 7) suggested that the majority of the expressed
proteins were myristoylated.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 6.
Localization of NCS proteins in transfected
HeLa cells permeabilized with digitonin in the presence or absence of
10 µM Ca2+. The
localization pattern of NCS-1-ECFP was unaffected by the
permeabilization in digitonin for 15 min and the presence
(A) or absence (B) of calcium. The localization
of hippocalcin-EYFP was affected dramatically by the presence or
absence of calcium during permeabilization. Hippocalcin-EYFP rapidly
translocated to the perinuclear region in the presence of high calcium
(C). When calcium was absent hippocalcin-EYFP leaked from
the cells (D), although in some cells the fluorescent
protein remained trapped in the nucleus. Neurocalcin in transfected
cells was detected using anti-neurocalcin antiserum. It was also
translocated to the perinuclear compartment in the presence of 10 µM Ca2+ (E) and was lost from the
cells in the absence of Ca2+ (F). The
scale bar represents 20 µm.
|
|

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 7.
Detection by Western blotting of retained and
leaked proteins from transfected HeLa cells after digitonin
permeabilization. Transfected HeLa cells were permeabilized for 15 min in the absence or presence of 10 µM Ca2+,
and samples of the cells and medium probed with anti-GFP for
pNCS-1-ECFP and pHippo-EYFP-transfected cells and with anti-neurocalcin
for pNeurocalcin -transfected cells.
|
|
Requirement for Ca2+ Binding and Myristoylation for
Perinuclear Localization of NCS Proteins--
The data so far showed
that localization of NCS-1-ECFP to the perinuclear compartment was
independent of Ca2+ concentration in intact and
permeabilized cells. To confirm that Ca2+ binding was not
required for the localization of NCS-1, use was made of constructs
encoding untagged wild-type NCS-1 and a version with all three
functional EF hands (EF2-4) mutated to eliminate Ca2+
binding. These mutations (E84Q, E120Q, and E168Q) replaced conserved acidic residues in the EF hands required for Ca2+
coordination (18). Cells were fixed after permeabilization, and NCS-1
localization was determined by immunofluorescence staining. The
untagged wild-type protein was found to be localized to the perinuclear
compartment in the presence or absence of Ca2+ (Fig.
8, A and B) as
previously seen for NCS-1-ECFP. The same localization pattern was seen
with the NCS-1(EF2-4) mutant, indicating a complete lack of dependence
on Ca2+ binding for the localization of NCS-1 (Fig. 8,
C and D).

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 8.
Localization of NCS-1 to the perinuclear
compartment does not require Ca2+ binding. HeLa cells
were transfected with plasmids encoding wild-type untagged NCS-1
(A and B) or NCS-1(EF2-4) with mutations in all
three functional EF hands (C and D). Cells were
permeabilized with digitonin in the presence or absence of 10 µM Ca2+ for 15 min and fixed for
immunocytochemical staining with anti-NCS-1. Both wild-type and the
NCS-1(EF2-4) mutant were associated with the perinuclear compartment
irrespective of Ca2+ concentration. The scale
bar represents 20 µm.
|
|
To determine whether myristoylation of the NCS proteins was required
for their localization and translocation, constructs were made with the
second glycine residue, essential for myristoylation (31), mutated to
an alanine in both the NCS-1 and hippocalcin fusion proteins. Fig.
9 shows that intact cells transfected
either with pHippo(G2A)-EYFP or pNCS-1(G2A)-ECFP showed a diffuse
fluorescence pattern compatible with cytosolic localization of the
proteins (Fig. 9, A and C). No indication of
translocation was seen in response to elevated intracellular
Ca2+ levels. In addition, when the cells were
permeabilized, even in the presence of 10 µM free
Ca2+, the unmyristoylated fusion proteins rapidly leaked
out of the cells with only low levels of fluorescence remaining in the
nuclei (Fig. 9, B and D). These data indicate
that myristoylation was essential for the perinuclear localization of
NCS-1 and for Ca2+-dependent translocation of
hippocalcin.

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 9.
Localization and translocation of NCS
proteins requires myristoylation. HeLa cells were transfected with
plasmids encoding hippocalcin-EYFP (A and B) and
NCS-1-ECFP (C and D), each with a mutation (G2A)
to remove the myristoylated glycine residue or with a construct
consisting of the minimal myristoylation sequence (residues 1-14 of
hippocalcin). In intact cells hippocalcin (G2A)-EYFP and
NCS-1(G2A)-ECFP had a diffuse location, and both proteins were lost
from the cells following permeabilization with digitonin for 15 min in
the presence of 10 µM Ca2+.
Hippocalcin-(1-14)-EGFP was associated with a perinuclear compartment
in both intact and permeabilized cells. The scale
bar represents 20 µm.
|
|
To determine the degree to which the exposure of the myristoyl tail
was sufficient for perinuclear membrane localization, a construct was
made that fused the myristoylation sequence taken from hippocalcin
(hippocalcin-(1-14)) to EGFP. This was expressed in HeLa cells, and
its localization is shown in Fig. 9E. The distribution of
the hippocalcin-(1-14)-EGFP protein appeared to be much the same as
the perinuclear localization of the NCS proteins. There was strong
perinuclear fluorescence together with some possible plasma membrane
localization. This indicates that the myristoyl tail can be the sole
determinant for intracellular targeting of these proteins. Using the
permeabilization assay in 0 Ca2+ solution, it was found
that the hippocalcin-(1-14)-EGFP remained in the cells, concentrated
in the perinuclear region (Fig. 9F). This demonstrated that
the myristoyl group accounted for all the intracellular targeting
seen with the NCS-1 and hippocalcin fusion proteins but not the
Ca2+ dependence of hippocalcin localization.
Kinetics of the Ca2+/Myristoyl Switch in Living
Cells--
To examine the kinetics of the
Ca2+-dependent translocation of
hippocalcin-EYFP, live cells were imaged using confocal laser scanning
microscopy and fluorescence was monitored following addition of
ionomycin (Fig. 10). Cells initially
showed a diffuse fluorescence indicative of cytosolic and nuclear
localization. Within a few seconds of ionomycin addition, translocation
of hippocalcin-EYFP occurred with the appearance of a bright punctate
spots with a perinuclear localization. In addition, hippocalcin-EYFP
also appeared to a lesser extent associated with the plasma
membrane in distinct patches (arrows in the last
frame of Fig. 10), confirming the earlier interpretation
from epifluorescence microscopy. The time course of translocation was
similar to that previously seen for the
Ca2+-dependent C2 domain of PKC
(6) or the pH domain of PLC
(32). Translocation of hippocalcin-EYFP
was also observed under more physiological conditions following
stimulation with histamine and was reversible several minutes after
the initial
translocation.2

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 10.
Confocal laser scanning microscopy showing
the time course of translocation of hippocalcin-EYFP in response to
Ca2+ elevation. HeLa cells transfected with
pHippo-EYFP were imaged using confocal microscopy, and the panels show
a compilation of time-lapse images at the times indicated from 0 to
68.4 s. In this series, frames were taken every 1.9 s to give
optimal spatial resolution. Addition of ionomycin at time 0 was
followed by translocation of hippocalcin-EYFP to perinuclear vesicular
structures and to patches on the plasma membrane (arrows in
the last frame). The scale
bar represents 20 µm.
|
|
The relationship of kinetics of the Ca2+/myristoyl switch
for membrane translocation to changes in cytosolic Ca2+
concentration was examined in cells expressing hippocalcin-EYFP and
loaded with the fluorescence Ca2+ indicator Fura Red. Dual
imaging using confocal microscopy indicated that changes in
hippocalcin-EYFP localization could be measured in parallel with an
expected decrease in Fura Red emission because of Ca2+
elevation following ionomycin addition. Measurement at high time resolution (1 frame/137 ms) allowed a comparison of the time course of
hippocalcin-EYFP translocation and changes in cytosolic
Ca2+ concentration (Fig.
11). Cytosolic Ca2+
concentration was monitored over the whole cell. Translocation was
assessed by monitoring the fluorescence of 9 spots/cell where translocation occurred and averaging the time courses for each cell.
Cytosolic Ca2+ concentration began to increase in a
homogeneous manner over the whole cell immediately upon
ionomycin addition. In contrast, hippocalcin-EYFP translocation began
only after a lag period of ~2 s (2.17 ± 0.13 s from 4 cells). The time course of translocation, which then followed, could be
fitted with a single hyperbolic function, indicating a first order
reaction, with a half-time of ~12 s.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 11.
Kinetics of changes in cytosolic
Ca2+ concentration and hippocalcin-EYFP translocation.
HeLa cells transfected to express hippocalcin-EYFP were loaded
with Fura Red and imaged by confocal microscopy. To provide optimal
time resolution, frames were taken every 137 ms. The decrease in Fura
Red fluorescence (top) began as soon as ionomycin was added.
The lower panel shows averaged data from 9 regions of translocation in the same cell. The standard errors of the
means are not shown for clarity but did not exceed ±4% of the mean
values. Translocation began after a 2-s lag and then followed first
order kinetics (as shown by the fitted curve) with a half-time of
11.6 s.
|
|
 |
DISCUSSION |
It has become increasingly apparent that the control
of various cellular activities involves proteins that either are
tightly co-localized in signaling complexes or can translocate in a
dynamic way into such complexes (33, 34). Studies on protein dynamics have been complemented by increasing information on the differential use of local versus global Ca2+ signals in the
regulation of cell function (2). In contrast, relatively little is
known about the dynamics and localization of Ca2+ sensor
proteins apart from calmodulin and protein kinase C (3-6). Here we
have examined the localization of three members of the NCS family of
Ca2+ sensors and demonstrate that, under the same
conditions in the same cellular context, their N-terminal myristoyl
groups are used in quite different ways to determine their
localization. We also provide data on the kinetics of the
Ca2+-myristoyl switch mechanism in living cells. The
classic example of the NCS proteins has been the well characterized
retinal protein recoverin, which is believed to show
Ca2+-dependent translocation to membranes via a
Ca2+/myristoyl switch mechanism based on biochemical and
structural analyses (14-16), although this has not been confirmed in
living cells. The differences in behavior we observed for other NCS
proteins are surprising, as the features within the sequence of
recoverin that determine the Ca2+/myristoyl switch
mechanism including the inactivated first EF hand and hydrophobic
residues that cradle the myristoyl group are highly conserved in all of
the NCS proteins (15). It has recently been shown, however, that
residues within EF1 of GCAP-2 are crucial for binding to guanylyl
cyclase (35). The inactivated EF hand may therefore be more generally
important in NCS proteins for target protein interactions.
In HeLa cells, NCS-1 was constitutively associated with, and
hippocalcin and neurocalcin
could become associated with, membranes of a perinuclear compartment overlapping the trans-Golgi network (shown
using
adaptin as the marker). All three proteins also appeared to
associate with the plasma membrane. This localization was not dependent
on the presence of the fluorescent tags and is likely to be the result
of the preference of the myristoyl group for cholesterol- and
sphingolipid-rich domains (36). Although hippocalcin and neurocalcin
are expressed only in neurons, NCS-1 is expressed in many
non-neuronal cell types (23, 28, 37). Association with a perinuclear
compartment overlapping the trans-Golgi was reported for endogenous
NCS-1 in COS-7 cells (28). Importantly, studies on NCS-1 in fixed brain
slices indicated by the use of electron microscopy that NCS-1 was
present on cisternae of the trans-Golgi complex, in addition to its
presence in both pre- and post-synaptic structures (38). The
Ca2+ dependence of the localization of NCS-1 to the
trans-Golgi was not determined in these studies, and so it remained
possible that resting cytosolic Ca2+concentration was
sufficient to activate a Ca2+/myristoyl switch in NCS-1 as
it has a high affinity for Ca2+ (24, 39). We have
demonstrated here that NCS-1 association with the perinuclear
compartment is independent of free Ca2+and that NCS-1 does
not need functional Ca2+-binding motifs for this
localization. The presence of NCS-1 on the trans-Golgi network may be
related to its regulation of PI 4-kinase
(28, 29), which has the
same localization. The ability of other NCS proteins such
as hippocalcin and neurocalcin
to interact with PI 4-kinase
has
not been examined, and their localization in neurons has only been
investigated after fixation without elevation of intracellular
Ca2+. The presence of NCS-1 on the plasma membrane that we
have observed would be consistent with the known involvement of NCS-1
in Ca2+ channel regulation (25, 26).
The membrane association of NCS-1 and hippocalcin in HeLa
cells was entirely dependent upon myristoylation. In addition, a minimal myristoylation sequence (hippocalcin-(1-14)) was sufficient for localization to the perinuclear compartment. The latter result is
compatible with previous work on the targeting of constructs bearing
the myristoylation sequence of Src family kinases (40). The difference
between the NCS proteins that we investigated, however, was that NCS-1
was membrane-associated even at nominally 0 Ca2+, whereas
hippocalcin and neurocalcin
required Ca2+ elevation
above resting levels to translocate from the cytosol to a
membrane-associated pool. The membrane association of NCS-1 additionally did not require the presence of any functional EF hand
motifs. These data suggest that, in NCS-1, the myristoyl group is
exposed even in the Ca2+ free form but that hippocalcin and
neurocalcin
have a classic recoverin-like
Ca2+/myristoyl switch. Their myristoyl group would,
therefore, be sequestered in the Ca2+-free form and then
exposed in the Ca2+-bound form to allow the proteins to
become membrane-associated. The findings on NCS-1 are consistent with
biochemical data showing that recombinant myristoylated NCS-1 became
bound to membranes in the absence of Ca2+ (24). In
addition, analysis of the yeast orthologue FRQ1 by NMR suggested that
the myristoyl group might always be solvent-exposed (41). This idea
could be directly confirmed by x-ray crystallography, but so far the
only structure solved is for nonmyristoylated NCS-1 in its
Ca2+-bound form (28). The study of yeast FRQ also showed,
from a biochemical analysis of cell fractions, that some
Ca2+-dependent membrane association occurred
even in the absence of myristoylation (41). In contrast, in intact or
permeabilized HeLa cells, NCS-1 localization to the perinuclear
membrane compartment was completely dependent upon its myristoylation.
This may reflect differences in behavior of the proteins when examining
them in a cellular context or in cell extracts and demonstrates the
importance of carrying out these studies on proteins within cells.
The different usage of the myristoyl group in the NCS
proteins is likely to be important for differential aspects of
Ca2+ signal transduction. EF hand motifs in
Ca2+ sensors bind Ca2+ very rapidly with
binding limited only by the rate of Ca2+ diffusion (42).
The off-rate is also rapid in Ca2+ sensors but can be
slowed in Ca2+-sensor and Ca2+-buffer proteins
by changes in the residue at position 9 of the EF hand (42). This
allows fine-tuning of the kinetics of activation and time scale of
activity of EF hand proteins. The NCS proteins show the properties of
fast Ca2+ sensors with rapid on- and off-rates of
Ca2+ binding and inactivation occurring on a millisecond
time scale (43, 44). It would be predicted that NCS-1, with an affinity of 0.3 µM, would be able to react to Ca2+
concentration changes in a time course of no more than milliseconds and
retain its bound Ca2+ with a time constant of ~20 ms when
Ca2+ concentration falls (see similar calculations for
GCAP1 (Ref. 44)). In contrast, hippocalcin and neurocalcin
would
respond to more global Ca2+ signals and only be able to
exert their regulatory effects at target membranes after translocation
from the cytosol. This would also require the Ca2+
elevation to last over seconds and could preclude activation of
hippocalcin and neurocalcin
by brief localized Ca2+
pulses. NCS-1 appears, therefore, to be a protein that would be able to
sense and transduce transient and local Ca2+ signals
occurring close to the membranes to which it is attached on a
millisecond time scale, whereas other NCS proteins such as hippocalcin
and neurocalcin
would have a different spatio-temporal pattern of
activation requiring longer lasting Ca2+ elevations.
The dual imaging of both hippocalcin-EYFP localization and cytosolic
Ca2+ concentration in living cells provides information on
the kinetics of the Ca2+/myristoyl switch and membrane
translocation in vivo. Hippocalcin and neurocalcin
have
high affinities for Ca2+ when assayed in vitro
(17, 18), and it is conceivable that membrane association could occur
already at resting cytosolic Ca2+ concentration. We have
shown, however, that membrane association of hippocalcin-EYFP does
require Ca2+ elevation above resting levels, and that this
occurs with a half-time of ~12s and follows a short (2 s) lag period
after Ca2+ elevation. The translocation kinetics were
consistent with a first-order reaction. These results are consistent
with a rapid conformational change in the protein on Ca2+
binding followed by a diffusion-limited translocation to membranes. The
time course over which hippocalcin-EYFP accumulates indicates that it
would function in Ca2+ signal transduction over seconds and
thus be a considerably slower Ca2+ sensor in
vivo than NCS-1.
NCS-1 is the evolutionarily most ancient of the NCS
proteins being represented in yeast (27). An additional form most
similar to neurocalcin
is present in nematodes, and other NCS
proteins appeared later in evolution (7). It seems that an event must have occurred during evolution whereby a membrane-anchored protein NCS-1 gave rise to new forms in which the myristoyl group is
sequestered in the Ca2+-free form of the protein and thus
used in a radically different way. It is likely that further
alterations in the use of the myristoyl group of NCS protein has
arisen; it is known, for example, from biochemical assays that the
photoreceptor protein GCAP-2 shows a reversed
Ca2+-dependent membrane association and
dissociates from membranes as Ca2+ is elevated (45). This
family of Ca2+ sensors, therefore, provides an intriguing
example of how a single post-translational modification, N-terminal
myristoylation, has been adapted during evolution to allow the
appearance of a diverse family of proteins able to mediate distinct
spatial and temporal patterns of Ca2+ signal transduction.
 |
FOOTNOTES |
*
This work was supported in part by a grant from the Wellcome
Trust (to R. D. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by Wellcome Trust Prize studentships.
§
To whom correspondence should be addressed. Tel.:
44-151-794-5305; Fax: 44-151-794-5337; E-mail:
burgoyne@liverpool.ac.uk.
Published, JBC Papers in Press, February 8, 2002, DOI 10.1074/jbc.M111750200
2
D. W. O'Callaghan, L. Ivings, J. L. Weiss, M. C. Ashby, A. V. Tepikin, and R. D. Burgoyne,
unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
NCS, neuronal
calcium sensor;
GCAP, guanylyl cyclase-activating protein;
VILIP, visinin-like protein;
PI, phosphatidylinositol;
GFP, green
fluorescent protein;
PIPES, 1,4-piperazinediethanesulfonic acid;
PBS, phosphate-buffered saline.
 |
REFERENCES |
| 1.
|
Berridge, M. J.,
Lipp, P.,
and Bootman, M. D.
(2000)
Nat. Rev. Mol. Cell. Biol.
1,
11-21[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Bootman, M. D.,
Lipp, P.,
and Berridge, M. J.
(2001)
J. Cell Sci.
114,
2213-2222[Abstract/Free Full Text]
|
| 3.
|
Teruel, M. N.,
Chen, W.,
Persechini, A.,
and Meyer, T.
(2000)
Curr. Biol.
10,
86-94[Medline]
[Order article via Infotrieve]
|
| 4.
|
Craske, H.,
Takeo, T.,
Gerasimenko, O.,
Vaillant, C.,
Torok, K.,
Petersen, O. H.,
and Tepikin, A. V.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4426-4431[Abstract/Free Full Text]
|
| 5.
|
Deisseroth, K.,
Heist, E. K.,
and Tsien, R. W.
(1998)
Nature
392,
198-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Oancea, E.,
and Meyer, T.
(1998)
Cell
95,
307-318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Burgoyne, R. D.,
and Weiss, J. L.
(2001)
Biochem. J.
353,
1-12[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Ray, S.,
Zozulya, S.,
Niemi, G. A.,
Flaherty, K. M.,
Brolley, D.,
Dizhoor, A. M.,
Mckay, D. B.,
Hurley, J. B.,
and Stryer, L.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5705-5709[Abstract/Free Full Text]
|
| 9.
|
Dizhoor, A. M.,
Olshevskaya, E. V.,
Henzel, W. J.,
Wong, S. C.,
Stults, J. T.,
Ankoudinova, I.,
and Hurley, J. B.
(1995)
J. Biol. Chem.
270,
25200-25206[Abstract/Free Full Text]
|
| 10.
|
Kobayashi, M.,
Takamatsu, K.,
Saitoh, S.,
Miura, M.,
and Noguchi, T.
(1992)
Biochem. Biophys. Res. Commun.
189,
511-517[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Okazaki, K.,
Watanabe, M.,
Ando, Y.,
Hagiwara, M.,
Terasawa, M.,
and Hidaka, H.
(1992)
Biochem. Biophys. Res. Commun.
185,
147-153[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Pongs, O.,
Lindemeier, J.,
Zhu, X. R.,
Theil, T.,
Endelkamp, D.,
Krah-Jentgens, I.,
Lambrecht, H.-G.,
Koch, K. W.,
Schwemer, J.,
Rivosecchi, R.,
Mallart, A.,
Galceran, J.,
Canal, I.,
Barbas, J. A.,
and Ferrus, A.
(1993)
Neuron
11,
15-28[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Nef, S.,
Fiumelli, H.,
de Castro, E.,
Raes, M.-B.,
and Nef, P.
(1995)
J. Receptor Signal Trans.
15,
365-378
|
| 14.
|
Zozulya, S.,
and Stryer, L.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
11569-11573[Abstract/Free Full Text]
|
| 15.
|
Tanaka, T.,
Ames, J. B.,
Harvey, T. S.,
Stryer, L.,
and Ikura, M.
(1995)
Nature
376,
444-447[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Ames, J. B.,
Ishima, R.,
Tanaka, T.,
Gordon, J. I.,
Stryer, L.,
and Ikura, M.
(1997)
Nature
389,
198-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Kobayashi, M.,
Takamatsu, K.,
Saitoh, S.,
and Noguchi, T.
(1993)
J. Biol. Chem.
268,
18898-18904[Abstract/Free Full Text]
|
| 18.
|
Ladant, D.
(1995)
J. Biol. Chem.
270,
3179-3185[Abstract/Free Full Text]
|
| 19.
|
Saitoh, S.,
Takamatsu, K.,
Kobayashi, M.,
and Noguchi, T.
(1994)
Dev. Brain Res.
80,
199-208[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Spilker, C.,
Richter, K.,
Smalla, K. H.,
Manahan-Vaughan, D.,
Gundelfinger, E. D.,
and Braunewell, K. H.
(2000)
Neuroscience
96,
121-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Paterlini, M.,
Revilla, V.,
Grant, A. L.,
and Wisden, W.
(2000)
Neuroscience
99,
205-216[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Gomez, M., De,
Castro, E.,
Guarin, E.,
Sasakura, H.,
Kuhara, A.,
Mori, I.,
Bartfai, T.,
Bargmann, C. I.,
and Nef, P.
(2001)
Neuron
30,
241-248[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
McFerran, B. W.,
Graham, M. E.,
and Burgoyne, R. D.
(1998)
J. Biol. Chem.
273,
22768-22772[Abstract/Free Full Text]
|
| 24.
|
McFerran, B. W.,
Weiss, J. L.,
and Burgoyne, R. D.
(1999)
J. Biol. Chem.
274,
30258-30265[Abstract/Free Full Text]
|
| 25.
|
Weiss, J. L.,
Archer, D. A.,
and Burgoyne, R. D.
(2000)
J. Biol. Chem.
275,
40082-40087[Abstract/Free Full Text]
|
| 26.
|
Weiss, J. L.,
and Burgoyne, R. D.
(2001)
J. Biol. Chem.
276,
44804-44811[Abstract/Free Full Text]
|
| 27.
|
Hendricks, K. B.,
Wang, B. Q.,
Schnieders, E. A.,
and Thorner, J.
(1999)
Nat. Cell Biol.
1,
234-241[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Bourne, Y.,
Dannenberg, J.,
Pollmann, V.,
Marchot, P.,
and Pongs, O.
(2001)
J. Biol. Chem.
276,
11949-11955[Abstract/Free Full Text]
|
| 29.
|
Zhao, X.,
Varnai, P.,
Tuymetovna, G.,
Balla, A.,
Toth, Z. E.,
Oker-Blom, C.,
Roder, J.,
Jeromin, A.,
and Balla, T.
(2001)
J. Biol. Chem.
276,
40183-40189[Abstract/Free Full Text]
|
| 30.
|
Chamberlain, L. H.,
Roth, D.,
Morgan, A.,
and Burgoyne, R. D.
(1995)
J. Cell Biol.
130,
1063-1071[Abstract/Free Full Text]
|
| 31.
|
Duronio, R. J.,
Jackson-Machelski, E.,
Heuckroth, R. O.,
Olins, P. O.,
Devine, C. S.,
Yonemoto, W.,
Slice, L. W.,
Taylor, S. S.,
and Gordon, J. I.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
1506-1510[Abstract/Free Full Text]
|
| 32.
|
Hirose, K.,
Kadowaki, S.,
Tanabe, M.,
Takeshima, H.,
and Lino, M.
(1999)
Science
284,
1527-1530[Abstract/Free Full Text]
|
| 33.
|
Teruel, M. N.,
and Meyer, T.
(2000)
Cell
103,
181-184[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Hurley, J. H.,
and Meyer, T.
(2001)
Curr. Opin. Cell Biol.
13,
146-152[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Ermilov, A. N.,
Olshevskaya, E. V.,
and Dizhoor, A. M.
(2001)
J. Biol. Chem.
27 |